Duke Surgeon Unveils Partial Heart Transplant Innovation to Solve Growth Challenges for Children

Dr. Joseph Turek details how partial heart transplants provide living valves that grow with children, potentially saving thousands of lives each year.

By: AXL Media

Published: Apr 24, 2026, 3:25 AM EDT

Source: Information for this report was sourced from International Society for Heart and Lung Transplantation

A Surgical Revolution for Congenital Valve Defects

The field of pediatric cardiology has reached a pivotal milestone with the formal presentation of partial heart transplantation as a standardizable clinical reality. Addressing the International Society for Heart and Lung Transplantation in Toronto, Dr. Joseph Turek of Duke University confirmed that this innovation is now reproducible and ready to scale. Unlike traditional full heart replacements, this focused surgery targets only the defective valves and supporting structures, directly addressing the needs of more than 330,000 children globally who require valve interventions every year.

The Domino Effect of Organ Repurposing

The core of this medical advancement lies in what Dr. Turek describes as a domino effect of traditional transplantation logistics. When a patient receives a full heart transplant due to muscle failure or coronary artery disease, the valves within the discarded heart are often structurally perfect. By harvesting these living valves, surgeons can provide a second patient with a "partial" transplant. According to Dr. Turek, the 5,000 full heart transplants performed annually in the United States could theoretically yield up to two usable valves each, potentially creating a secondary supply of thousands of grafts for infants who would otherwise face a lifetime of risky surgeries.

Overcoming the Stagnancy of Artificial Grafts

The primary clinical advantage of partial heart transplantation is the biological capacity for growth. Traditional artificial or animal-derived valves are static, meaning they do not expand as a child’s body matures, inevitably leading to a cycle of high-risk replacement operations. Living pediatric valve tissue, however, integrates into the recipient’s anatomy and scales with their development. This "one-and-done" potential significantly lowers the cumulative surgical trauma and long-term mortality risk for the youngest and most vulnerable cardiac patients.